three-period six sequence crossover
Showing 1 - 25 of >10,000
Pharmacokinetics Trial in San Antonio (Nalmefene Hydrochloride)
Completed
- Opioid Overdose
- Nalmefene Hydrochloride
-
San Antonio, TexasWorldWide Clinical Trials
Dec 8, 2022
Healthy Volunteers Trial in Madison (Apremilast Tablet, Apremilast Oral Suspension)
Completed
- Healthy Volunteers
- Apremilast Tablet
- Apremilast Oral Suspension
-
Madison, WisconsinCovance Clinical Research Unit Inc
Jul 14, 2021
Infectious Disease, Drug Effect, Clinical Infection Trial (Azithromycin Oleogel (Oral and Rectal))
Not yet recruiting
- Infectious Disease
- +2 more
- Azithromycin Oleogel (Oral and Rectal)
- (no location specified)
Mar 31, 2023
Drug Drug Interaction Trial in Seoul (DWP14012, DWC202202, DWC202203)
Recruiting
- Drug Drug Interaction
- DWP14012
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 6, 2022
Drug Interaction Trial in Beijing (ZX-7101A, Oseltamivir, ZX-7101A and Oseltamivir)
Recruiting
- Drug Interaction
- ZX-7101A
- +2 more
-
Beijing, Beijing, ChinaPeking University Third Hospital
Sep 21, 2023
Healthy Adult Subjects Trial in San Antonio (TTYP01, Radicava, Radicava ORS)
Recruiting
- Healthy Adult Subjects
- TTYP01
- +2 more
-
San Antonio, TexasICON Early Phase Services
Oct 24, 2023
Epilepsy Trial in Wuhan (Lacosamide Tablets, Lacosamide extended release tablets)
Not yet recruiting
- Epilepsy
- Lacosamide Tablets
- Lacosamide extended release tablets
-
Wuhan, Hubei, ChinaUnion Hospital of Tongji Medical College of Huazhong University
Mar 15, 2023
Stroke Sequelae, Stroke Trial in Anyang-si (NDC-002)
Completed
- Stroke Sequelae
- Stroke
-
Anyang-si, Korea, Republic ofInsan Medical Foundation Metro Hospital
Oct 22, 2023
Healthy Adult Subjects Trial in Tempe (Omaveloxolone, Efavirenz)
Not yet recruiting
- Healthy Adult Subjects
-
Tempe, ArizonaCelerion, Inc.
Jun 16, 2023
Mantle Cell Lymphoma Trial in Hangzhou (LP-168 tablet)
Recruiting
- Mantle Cell Lymphoma
- LP-168 tablet
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital, School of Medicine, Zhejiang Univers
Jun 24, 2023
Relapsed or Refractory Lymphoma Trial in Austin (HMPL-523, Itraconazole, Rifampin)
Active, not recruiting
- Relapsed or Refractory Lymphoma
- HMPL-523
- +2 more
-
Austin, TexasPPD Austin
Jan 31, 2023
Heparin-induced Thrombocytopenia Trial in Lincoln (VLX-1005, Argatroban)
Completed
- Heparin-induced Thrombocytopenia
-
Lincoln, NebraskaCelerion, Inc.
Jan 10, 2023
Asthma Trial (Glycopyrronium bromide 25ug, Placebo, Glycopyrronium bromide 12.5ug)
Recruiting
- Asthma
- Glycopyrronium bromide 25ug
- +2 more
-
Ruse, Bulgaria
- +11 more
Jan 23, 2023
Healthy Volunteers Trial in Neuss (Biocon's Human Insulin R U-500, Humulin® R U-500 (US Reference Product))
Recruiting
- Healthy Volunteers
- Biocon's Human Insulin R U-500
- Humulin® R U-500 (US Reference Product)
-
Neuss, GermanyProfil Institut für Stoffwechselforschung GmbH 9
Jun 9, 2022
Pharmacokinetics Trial in Fargo (PrimeC-ER 748 mg, Ciprofloxacin 750 MG, Celecoxib 200mg)
Completed
- Pharmacokinetics
- PrimeC-ER 748 mg
- +2 more
-
Fargo, North DakotaNovum
Oct 23, 2022
Carpal Tunnel Syndrome Trial in Helsinki, Jyväskylä, Tampere (splinting)
Recruiting
- Carpal Tunnel Syndrome
- splinting
-
Helsinki, Finland
- +3 more
Dec 29, 2022